Cargando…
Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide
Various screening tools have been proposed to identify HIV-Associated Neurocognitive Disorder (HAND). However, there has been no systematic review of their strengths and weaknesses in detecting HAND when compared to gold standard neuropsychological testing. Thirty-five studies assessing HAND screens...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851699/ https://www.ncbi.nlm.nih.gov/pubmed/24072534 http://dx.doi.org/10.1007/s11904-013-0176-6 |
_version_ | 1782294332651339776 |
---|---|
author | Kamminga, Jody Cysique, Lucette A. Lu, Grace Batchelor, Jennifer Brew, Bruce J. |
author_facet | Kamminga, Jody Cysique, Lucette A. Lu, Grace Batchelor, Jennifer Brew, Bruce J. |
author_sort | Kamminga, Jody |
collection | PubMed |
description | Various screening tools have been proposed to identify HIV-Associated Neurocognitive Disorder (HAND). However, there has been no systematic review of their strengths and weaknesses in detecting HAND when compared to gold standard neuropsychological testing. Thirty-five studies assessing HAND screens that were conducted in the era of combination antiretroviral therapy were retrieved using standard search procedures. Of those, 19 (54 %) compared their screen to standard neuropsychological testing. Studies were characterised by a wide variation in criterion validity primarily due to non-standard definition of neurocognitive impairment, and to the demographic and clinical heterogeneity of samples. Assessment of construct validity was lacking, and longitudinal useability was not established. To address these limitations, the current review proposed a summary of the most sensitive and specific studies (>70 %), as well as providing explicit caution regarding their weaknesses, and recommendations for their use in HIV primary care settings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11904-013-0176-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-3851699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-38516992013-12-05 Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide Kamminga, Jody Cysique, Lucette A. Lu, Grace Batchelor, Jennifer Brew, Bruce J. Curr HIV/AIDS Rep Behavioral Aspects of HIV Management (RJ DiClemente and JL Brown, Section Editors) Various screening tools have been proposed to identify HIV-Associated Neurocognitive Disorder (HAND). However, there has been no systematic review of their strengths and weaknesses in detecting HAND when compared to gold standard neuropsychological testing. Thirty-five studies assessing HAND screens that were conducted in the era of combination antiretroviral therapy were retrieved using standard search procedures. Of those, 19 (54 %) compared their screen to standard neuropsychological testing. Studies were characterised by a wide variation in criterion validity primarily due to non-standard definition of neurocognitive impairment, and to the demographic and clinical heterogeneity of samples. Assessment of construct validity was lacking, and longitudinal useability was not established. To address these limitations, the current review proposed a summary of the most sensitive and specific studies (>70 %), as well as providing explicit caution regarding their weaknesses, and recommendations for their use in HIV primary care settings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11904-013-0176-6) contains supplementary material, which is available to authorized users. Springer US 2013-09-27 2013 /pmc/articles/PMC3851699/ /pubmed/24072534 http://dx.doi.org/10.1007/s11904-013-0176-6 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Behavioral Aspects of HIV Management (RJ DiClemente and JL Brown, Section Editors) Kamminga, Jody Cysique, Lucette A. Lu, Grace Batchelor, Jennifer Brew, Bruce J. Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide |
title | Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide |
title_full | Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide |
title_fullStr | Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide |
title_full_unstemmed | Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide |
title_short | Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide |
title_sort | validity of cognitive screens for hiv-associated neurocognitive disorder: a systematic review and an informed screen selection guide |
topic | Behavioral Aspects of HIV Management (RJ DiClemente and JL Brown, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851699/ https://www.ncbi.nlm.nih.gov/pubmed/24072534 http://dx.doi.org/10.1007/s11904-013-0176-6 |
work_keys_str_mv | AT kammingajody validityofcognitivescreensforhivassociatedneurocognitivedisorderasystematicreviewandaninformedscreenselectionguide AT cysiquelucettea validityofcognitivescreensforhivassociatedneurocognitivedisorderasystematicreviewandaninformedscreenselectionguide AT lugrace validityofcognitivescreensforhivassociatedneurocognitivedisorderasystematicreviewandaninformedscreenselectionguide AT batchelorjennifer validityofcognitivescreensforhivassociatedneurocognitivedisorderasystematicreviewandaninformedscreenselectionguide AT brewbrucej validityofcognitivescreensforhivassociatedneurocognitivedisorderasystematicreviewandaninformedscreenselectionguide |